Merck & Co. (MRK) Q3 2022 Earnings Call Transcript
MRK earnings call for the period ending September 30, 2022.
Stay updated with breaking news from Stellar Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MRK earnings call for the period ending September 30, 2022.
ProQR Announces Fourth Quarter and Full Year 2020 Operating and Financial Results ProQR Announces Fourth Quarter and Full Year 2020 Operating and Financial Results Phase 2/3 pivotal Brighten pediatric trial of sepofarsen to begin in 2021; additional data from Phase 1/2 InSight extension study to be reported in H2 2021 QR-421a Stellar Phase 1/2 trial for Usher syndrome and non-syndromic retinitis pigmentosa interim analysis on track for late Q1/early Q2 2021 Further pipeline progress anticipated with first clinical data in 2021 from QR-1123 program for autosomal domi...